From patients - to patients
As a licensed Australian green-fields medicinal cannabis company – we care about our patients, our products and our planet.
At Sativite, we believe that all medical treatments should be personalised. That’s why we work closely with medical cannabis specialists, family doctors, pharmacists and other healthcare professionals to seek out and deliver a wide variety of high-quality products at affordable prices.
“Our mission is simple – to provide the best, sustainably produced medicinal cannabis products to patients in Australia and beyond.”
Mike Cleary, CEO
A ‘FINANCIAL FERTILISING’ will allow Moree’s fledgling medicinal cannabis sector to grow and create more than 25 new jobs, with Northern Tablelands MP Adam Marshall today announcing a $500,000 State Government grant for SatiVite Group’s Moree Special Activation Precinct (Moree SAP) project.
A Queensland woman who faced court on drug charges despite having a prescription for medicinal cannabis wants other unsuspecting users to be aware of the strict laws around carrying the substance.
In late 2021, the TGA changed the regulations around medicinal cannabis approvals and how they are handled. TGA approvals are now by category, not by product, creating several grey areas for patients and prescribers. Refer attached article to learn about what these changes mean for prescribers, pharmacists and patients.
Sativite CEO Mikes Cleary provides informal discussion on Medicinal Cannabis in Australia.